Abstract
Dialyzing membranes are often used in clinical circumstances and are an important factor in the consideration of biocompatibility with non-biological medical paraphernalia. Depending on the unique physical characteristics of the various filters employed, there are some significant side effects regard to cellular activation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Losito, V. Buoncristiani and C. Cecchini, Abnormal leucocyte locomotion induced by hemodialysis membranes, A clue to dialysis leukopenia. J Clin Lab Immunol 10:87 (1983)
B. Wierusz-Wysocka, H. Wysocki, R. Czarnecki, H. Siekierka, B. Kazimierz and K. Wysocki, Influence of hemodialysis on plasma chemotactic responsiveness of polymorphonuclear neutrophils. Artif Organs 7:159 (1983)
W. Marker, P.A. Waridel, C. Heierli and J.P, Wauters. Neutrophil functions during hemodialyis. Contrib Nephrol 62:99 (1988)
R.C: Vanholder, A. Dhondt and S.M.G. Ringoir, Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact: A biocompatible test. Trans Am Soc Artif Intern Organs 34:214 (1988)
M. Haag-Weber, G. Fiedler, P. Schollmeyer and W.H. Hörl, Activation of neutrophil glycogenolysis during hemodialysis. Blood (submitted for publication)
J. Metcoff, R. Lindemann, D. Baxter and J. Peterson, Cell metabolism in uremia. Am J Clin Nutr 30:1627 (1978)
B Descamps-Latscha, Phagocyte oxidative metabolism in hemodialysis. Contrib Nephrol 62:132 (1988)
D.E. Chenoweth, The properties of human C5a anaphylatoxins: The significance of C5a formation during hemodialysis. Contr Nephrol 59:51 (1987)
P. Ivanovich, D.E. Chenoweth, R. Schmidt, H. Klinkmann, L.A. Boxer, H.S. Jacobs and D.E.Hammerschmidt, Symptoms and activation of granulocytes and complement with two dialyzer membranes. Kidney Int 24:758 (1983)
R. Hällgren, P. Venge and B. Willström, Hemodialysis -induced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation. Nephron 29: 233 (1981)
W.H. Hörl, H.B. Steinhauer and P. Schollmeyer, Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 28:791 (1985)
W.H. Hörl, M. Jochum, A. Heidland and H. Fritz, Release of granulocyte proteinases during hemodialysis. Am J Nephrol 3:213 (1983)
W.H. Hörl, R.M. Schaefer, C. Wanner, J. Bahlmann, J. Reitinger, P. Schollmeyer and A. Heidland, Enhanced plasma and intracellular levels of main granulocyte components in diabetics on dialysis. Blood Purif (in press)
F. Knudsen, A.H. Nielsen and P.O. Pedersen, Leukopenia and release of granulocyte elastase: interlinked membrane -dependent events during hemodialysis. Blood Purif 2:36 (1984)
R.M. Schaefer, W.H. Hörl, K. Kokot and A. Heidland, Enhanced biocompatibility with a new cellulosic membrane:Cuprophan versus Hemophan. Blood Purif 5:262 (1987)
J. Bonal, C. Pastor, J Teixido, J Bonet, A. Serra, R. Lauzurica, R. Romero, A. Caralps and A. Corominas, Plasma levels of granulocyte elastase:its role on the assessment of hemodialysis membrane biocompatibility (abstract) Kidney Int 30:129 (1986)
K. Ohlsson and I. Ohlsson, Neutral proteases of human granulocytes. III: Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 34:349 (1974)
W.H. Hörl, W. Riegel, H.B. Steinhauer, C. Wanner, F Thaiss, F. Bozkurt, M. Haag and P. Schollmeyer, Granulocyte activation during hemodialysis. Clin Nephrol 26 (Suppl 1):S-30 (1986)
J.K. Spitznagel, Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes, in: “Neutral Proteases of Human Polymorphonuclear Leukocytes”, K. Havemann and A. Janoff, eds., Urban & Schwarzenberg, Baltimore-Munich (1978)
W. Schmidt, Differential release of elastase and chymotrypsin from polymorphonuclear leukocytes, in: “Neutral Proteases of Human Polymorphonuclear Leukocytes”, K. Havemann and A. Janoff, eds., Urban & Schwarzenberg, Baltimore-Munich (1978)
D.E. Chenoweth, A.K. Cheung and L.W. Henderson, Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. Kidney Int 24:764 (1983)
D.E. Chenoweth, A.K. Cheung, D.M. Ward and L.W. Henderson, Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers. Kidney Int 24:770 (1983)
D.E. Chenoweth, Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications. Artif Organs 8:281 (1984)
A.K. Cheung and L.W. Henderson, Effects of complement activation by hemodialysis membranes. Am J Nephrol 6:81 (1986)
R.M. Hakim, D.T. Fearon and J.M. Lazarus, Biocompatibility of dialysis membranes: effect of chronic complement activation. Kidney Int 26:194 (1984)
R.M. Hakim, J. Breillatt, J.M. Lazarus and F.K. Port, Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311:878 (1984)
W.H. Hörl and A. Heidland, Evidence for the participation of granulocyte proteinases on intradialytic catabolism. Clin Nephrol 21:314 (1984)
W.H. Hörl, W. Riegel, P. Schollmeyer, W. Rautenberg and S. Neumann, Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers. Clin Nephrol 25:304 (1986)
W.H. Hörl, W. Riegel and P. Schollmeyer, Plasma levels of main granulocyte components in patients dialyzed with polycarbonate and cuprophan membranes. Nephron 45:272 (1987)
R.M. Schaefer, A. Heidland and W.H. Hörl, Effect of dialyzer geometry on granulocyte and complement activation. Am J Nephrol 7:121 (1987)
C. Tetta, G. Camussi, G. Segoloni and A. Vercellone, Direct interaction between polymorphonuclear neutrophils (PMN) and dialysis membranes: role of the electrical charges (abstract). Kidney Int 29:609 (1986)
M. Haag-Weber, P. Schollmeyer and W.H. Hörl, Granulocyte activation in the absence of complement activation: inhibition by calcium channel blockers. Eur J Clin Invest 18:380 (1988)
W. Riegel, G. Spillner, V. Schlosser and W.H. Hörl, Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95:1014 (1988)
K. Kokot, M Teschner, R.M. Schaefer and A. Heidland, Stimulation and inhibition of elastase release from human neutrophil-dependence on the calcium messenger system. Mineral Electrolyte Metab 13:189 (1987)
M. Betz, G.M. Haenisch, E.W. Rauterberg, J. Bommer and E. Ritz, Cuprammonium membranes stimulate interleukin-1 release and arachidonic acid metabolism in monocytes in the absence of complement. Kidney Int 34:67 (1988)
A.T. Nguyen, C. Lethias, J. Zingraff, A. Herbelin, C. Naret and B. Descamps-Latscha, Hemodialysis membrane -induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 28:158 (1985)
G. Kolb, H. Schönemann, W. Fischer, K. Bittner, H. Lange, H. Höffken, V. Damann, K. Joseph and K. Havemann, Hemodialysis with cuprophan membranes lead to alteration of granulocyte oxidative metabolism and leucocyte sequestrion in the lung, in: “Proteases: Potential Role in Health and Disease II”, W.H. Hörl and A. Heidland, eds., Plenum, New York, p 2 (1988)
M. Markert, C. Heierli, T. Kuwahara, J. Frei and J.P. Wauters, Dialyzed polymorphonuclear neutrophil oxidative metabolism during dialysis: a comparative study with 5 new and reused membranes. Clin Nephrol 29:129 (1988)
M.L. McCaleb, M.S. Izzo and D.H. Lockwood, Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 75:391 (1985)
R.A. DeFronzo, J.D. Tobin, J.W. Rowe and R. Andres, Glucose intolerance in uremia. J. Clin Invest 62:425 (1978)
C.L. Hampers, J.S. Soeldner, P.B. Doak and J.P. Merrill,Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J. Clin Invest 45:1719 (1966)
P. Balestri, P. Rindi, M. Biagini and S. Giovanetti,Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism. Clin Sci 42:395 (1972)
J.M. Morgan and R.E. Morgan, Study of the effect of uremic metabolites on erythrocyte glycolysis. Metab Clin Exp 13:629 (1964)
R. Dzurik, Metabolic alterations caused by uremia. Proc Eur Dial Transplant Assoc 17:577 (1980)
M.L. McCaleb, R. Mevorach, R.B. Freeman, M.S. Izzo and D.H. Lockwood, Induction of insulin resistance in normal adipose tissue by uremic serum. Kidney Int 25:416 (1984)
H.M. Korchak, L.E. Rutherford and G. Weissmann, Stimulus response coupling in the human neutrophils. I. Kinetic analysis of changes in calcium permeability. J Biol Chem 259:4070 (1984)
Ch. McCall, J. Schmitt, S. Cousart, J. O’Flaherty, D. Bass and R. Wykle, Stimulation of hexose transport by human polymorphonuclear leucocytes: a possible role of protein kinase C. Biochem Biophys Res Comm 126:450 (1985)
K.H. Krause, W. Schlegel, C.B. Wollheim, T. Andersson, F.A. Waldvogel and P.D. Lew, Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol triphophate generation, calcium ion transients, and cellular activation. J. Clin Invest 76:1348 (1985)
M. Haag-Weber, M. Hable, P. Schollmeyer and W.H. Hörl, Hemodialysis improves carbohydrate metabolism in polymorphonuclear neutrophils (PMN) (abstract). Kidney Int 35:248 (1989)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this paper
Cite this paper
Haag-Weber, M., Schollmeyer, P., Hörl, W.H. (1989). Neutrophil Activation During Hemodialysis. In: Hörl, W.H., Schollmeyer, P.J. (eds) New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis. Advances in Experimental Medicine and Biology, vol 260. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5718-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5718-6_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5720-9
Online ISBN: 978-1-4684-5718-6
eBook Packages: Springer Book Archive